|Day Low/High||15.82 / 16.18|
|52 Wk Low/High||13.00 / 92.42|
Here's why the pharmaceutical company is a solid addition to your portfolio.
The two will split litigation fees 50-50.
L'Oreal stock falls more than 2% on Friday following an after-hours announcement on the future of the Body Shop.
L'Oreal is said to be working with Lazard on options for The Body Shop, as it focuses on skincare lines.
The aircraft components maker posted earnings of $2.57 a share on revenue of $814 million, beating analysts' forecasts.
The snack company will announce its full-year 2016 results on Tuesday.
Carrot-stick 'arrangement' with biotech is a fair tradeoff but will produce winners and losers.
Two industries should largely be avoided under this administration: pharma and retail.
A report calling the supplier the Valeant of aerospace was greeted with jeers from the sell side. There's reason for concerns about the company regardless.
Citron Research says TransDigm could be the Valeant of the Aerospace industry.
Doug Kass shares his thoughts on animal spirits, and discusses his astonishment at some rising optimism.
Wall Street secured gains again by late afternoon Wednesday in unpredictable trading following President-elect Donald Trump's first press conference since July.
CEO Joe Papa tried to distance the company from its past troubles at the annual J.P. Morgan Healthcare Conference.
Shares of the specialty pharmaceutical company were slightly higher on Wednesday after its CEO tried to reassure investors that the troubled company is moving in the right direction.
America Online and Time Warner see the 17-year anniversary of their combination come and go, as both companies are involved in separate merger dramas today.
The three major equity indices finished mixed, with the Nasdaq showing the best performance for the day.
A scattered day of trading leaves stocks mixed on Tuesday with the Nasdaq enjoying a record close for its third day in a row and the Dow lost ground again.
Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row.
Survey says: Maybe business is getting better.
Cramer looks back on his previous criticism of Valeant following L'Oreal deal.
Stocks turn higher Tuesday as crude oil declines and the fourth-quarter earnings season draws closer.
L'Oreal just wrote a huge check to Valeant.
U.S. stocks were mixed Tuesday. Investors are awaiting President-elect Donald Trump's first news conference since the election, which will be held Wednesday.
Stock futures are little changed on Tuesday as investors await news from a press conference Wednesday with President-elect Donald Trump. Oil prices level off.